BioEurope Spring 2015 Paris special

Bilbao, Spain - March 16, 2015

BioEurope Special Just back from the BioEurope Spring 2015 held in Paris, France. Quite intense meeting, over 2500 participants, 1300 companies registered, once again this is the opportunity to meet everybody in the biopharmaceutical arena, not just in Europe, but from all over the world. One of the highlights of this conference is the partnering session, where you get the chance to, in sort of a speed-dating format, get face-to-face interaction with partners, collaborators and potential clie...

Setting the basics for cancer stem cell research

Bilbao, Spain - March 06, 2015

Although the existence of cancer stem cells in solid tumors has been widely proven through experimentation, the Cancer Stem Cell model of tumor generation and progression still is the focus of some controversy and, mostly, misunderstanding.  Here the Stemtek Blog team will try to clarify some aspects about cancer and, specifically, about the so-called cancer stem cells (CSCs) everybody is talking about. Let’s start by defining what CSCs are (or are not). Stochastic or traditi...
StemTek Therapeutics activity is profiled in the February issue of EmpresaXXI, bi-weekly journal of the basque enterprise. A bio of Angel García Martín, one of StemTek founders, is shown on page 10.

Stem cells, cancer and “bad luck”

Bilbao, Spain - January 16, 2015

Just a few weeks ago a paper by Tomasetti and Vogelstein describing a mathematical model that correlates cancer incidence with the number of stem cell divisions in a plethora of human tissues was published in Science. This parameter is related to the cell replication activity of a particular tissue, ie, the cell turnover rate in that tissue, as some tissues renew their cells more slowly than others (compare brain tissue to intestinal epithelium). For about 2/3 of the tumors explored...
Back to top